Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts

Christopher Molvar; Robert Lewandowski

doi:10.1055/s-0035-1564704

Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts

Christopher Molvar^*, Robert Lewandowski

^*Corresponding author for this work

Radiology

Research output: Contribution to journal › Article › peer-review

Abstract

Hepatocellular carcinoma (HCC) is a lethal tumor, claiming over half a million lives per year. Treatment of HCC is commonly performed without curative intent, and palliative options dominate, including catheter-based therapies, namely, transarterial chemoembolization and yttrium-90 (⁹⁰Y) radioembolization. This review will showcase the performance of ⁹⁰Y radioembolization for the treatment of HCC, focusing on recent seminal data and technical advances. In particular, novel radioembolization treatment concepts are discussed and compared with conventional HCC therapy.

Original language	English (US)
Pages (from-to)	388-397
Number of pages	10
Journal	Seminars in Interventional Radiology
Volume	32
Issue number	4
DOIs	https://doi.org/10.1055/s-0035-1564704
State	Published - Dec 1 2015

Keywords

hepatocellular carcinoma
interventional radiology
liver cancer
radioembolization
therapy

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1055/s-0035-1564704

Fingerprint Dive into the research topics of 'Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts'. Together they form a unique fingerprint.

Cite this

@article{bff7623fd3f64126acb87601c1aeb8f1,

title = "Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts",

abstract = "Hepatocellular carcinoma (HCC) is a lethal tumor, claiming over half a million lives per year. Treatment of HCC is commonly performed without curative intent, and palliative options dominate, including catheter-based therapies, namely, transarterial chemoembolization and yttrium-90 (90Y) radioembolization. This review will showcase the performance of 90Y radioembolization for the treatment of HCC, focusing on recent seminal data and technical advances. In particular, novel radioembolization treatment concepts are discussed and compared with conventional HCC therapy.",

keywords = "hepatocellular carcinoma, interventional radiology, liver cancer, radioembolization, therapy",

author = "Christopher Molvar and Robert Lewandowski",

year = "2015",

month = dec,

day = "1",

doi = "10.1055/s-0035-1564704",

language = "English (US)",

volume = "32",

pages = "388--397",

journal = "Seminars in Interventional Radiology",

issn = "0739-9529",

publisher = "Thieme Medical Publishers",

number = "4",

}

TY - JOUR

T1 - Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts

AU - Molvar, Christopher

AU - Lewandowski, Robert

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Hepatocellular carcinoma (HCC) is a lethal tumor, claiming over half a million lives per year. Treatment of HCC is commonly performed without curative intent, and palliative options dominate, including catheter-based therapies, namely, transarterial chemoembolization and yttrium-90 (90Y) radioembolization. This review will showcase the performance of 90Y radioembolization for the treatment of HCC, focusing on recent seminal data and technical advances. In particular, novel radioembolization treatment concepts are discussed and compared with conventional HCC therapy.

AB - Hepatocellular carcinoma (HCC) is a lethal tumor, claiming over half a million lives per year. Treatment of HCC is commonly performed without curative intent, and palliative options dominate, including catheter-based therapies, namely, transarterial chemoembolization and yttrium-90 (90Y) radioembolization. This review will showcase the performance of 90Y radioembolization for the treatment of HCC, focusing on recent seminal data and technical advances. In particular, novel radioembolization treatment concepts are discussed and compared with conventional HCC therapy.

KW - hepatocellular carcinoma

KW - interventional radiology

KW - liver cancer

KW - radioembolization

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=84946706347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946706347&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1564704

DO - 10.1055/s-0035-1564704

M3 - Article

C2 - 26622103

AN - SCOPUS:84946706347

VL - 32

SP - 388

EP - 397

JO - Seminars in Interventional Radiology

JF - Seminars in Interventional Radiology

SN - 0739-9529

IS - 4

ER -